Comparing inflammatory cell density in the myocardium and coronary arteries in rheumatoid arthritis patients versus controls with myocardial infarction: A post-mortem case–control study  by van den Oever, Inge A.M. et al.
International Journal of Cardiology 209 (2016) 74–76
Contents lists available at ScienceDirect
International Journal of Cardiology
j ourna l homepage: www.e lsev ie r .com/ locate / i j ca rdCorrespondenceComparing inﬂammatory cell density in the myocardium and coronary
arteries in rheumatoid arthritis patients versus controls with myocardial
infarction: A post-mortem case–control studyInge A.M. van den Oever a,b,e,⁎,1, Alper M. van Sijl a,b,1, Umit Baylan c,1, Marieke M. ter Wee b,1,
Casper G. Schalkwijk d,1, Paul A.J. Krijnen c,1, Michael T. Nurmohamed a,b,1, Alexandre E. Voskuyl b,1,
Hans W.M. Niessen c,1, Suat Simsek e,1
a Department of Rheumatology, Amsterdam Rheumatology and Immunology Centre | Reade, Dokter Jan van Breemenstraat 2, 1056, AB, Amsterdam, The Netherlands
b Department of Rheumatology, Amsterdam Rheumatology and Immunology Centre | VU University Medical Centre, De Boelelaan 1117, 1081, HV, Amsterdam, The Netherlands
c Department of Pathology and Cardiac Surgery, ICaR-VU, VU University Medical Centre, De Boelelaan 1117, 1081, HV, Amsterdam, The Netherlands
d Department of Internal Medicine, UMCM, P. Debyelaan 25, 6229, HX, Maastricht, The Netherlands
e Department of Internal Medicine, Medical Centre Alkmaar, Wilhelminalaan 12, 1815, JD, Alkmaar, The Netherlands⁎ Corresponding author at: Department of Internal Med
Wilhelminalaan 12, 1815, JD, Alkmaar, The Netherlands.
E-mail address: I.A.M.vanden.Oever@mca.nl (I.A.M. va
1 This author takes responsibility for all aspects of the re
of the data presented and their discussed interpretation.
http://dx.doi.org/10.1016/j.ijcard.2016.02.065
0167-5273/© 2016 Elsevier Ireland Ltd. All rights reserveda r t i c l e i n f oArticle history:
Received 23 January 2016
Accepted 2 February 2016
Available online 3 February 2016
Keywords:
coronary arteries of RA patients [6].
We hypothesized that the systemic inﬂammatory process in RA, not
only leads to inﬂamed epicardial coronary arteries resulting in vulnera-
ble plaques, but also negatively affects the myocardial tissue and the
intramyocardial arteries. The present study analyzed the effect of RA
inMI patients at different levels: 1) the inﬂammatory status of epicardi-Rheumatoid arthritis
Coronary disease
Myocardial infarction
Inﬂammation
Post-mortemRheumatoid arthritis (RA) is a chronic inﬂammatory autoimmune
disease and associatedwith an increased risk of developing an unrecog-
nized but often fatal myocardial infarction (MI) [1,2]. Atherosclerosis is
considered an immune-mediated inﬂammatory disease, whereby large
numbers of active immune cells, including macrophages and lympho-
cytes, are found in the atherosclerotic plaque that can produce
inﬂammatory cytokines [3]. Increasing evidence suggests that the
intramyocardial vasculature also plays an important role in MI
induction [4]. We have shown depositions of the advanced glycation
endproduct (AGE) N-epsilon carboxy-methyl lysine (CML) in the
intramyocardial vasculature in advance of and subsequent to MI [5].
To date, only one study has actually compared atherosclerotic
plaques of coronary arteries in deceased RA patients with age- and
sex-matched controls. This study revealed less multivessel disease,
less severe grade of stenosis, but increased medial and adventitialicine, Medical Centre Alkmaar,
n den Oever).
liability and freedom from bias
.inﬂammation and an increased frequency of vulnerable plaques in
al coronary arteries; 2) the inﬂammatory status of intramyocardial
arteries; 3) inﬂammation of the heart post MI.
This is a retrospective case–control autopsy study. From a post-
mortem tissue database of subjects who underwent autopsy within
24 h after death at the Department of Pathology, VU University Medical
Centre (VUmc), Amsterdam, The Netherlands between January 1990
and December 2010, tissue-slides of the infarct related coronary artery
and myocardium of all subjects who were diagnosed with RA and an
acute MI at autopsy were selected and matched for age, sex, year of
death, grade of stenosis and infarct phase to control subjects without
RA, who were also diagnosed with MI at autopsy. The present study
was conducted in accordance with the Declaration of Helsinki and
according to the guidelines of the ethics committee of the VUmc. The
use of autopsy material after completion of the diagnostic process is
part of the patient informed consent in the VUmc.
Themyocardial tissue was taken from the infarct area (left ventricle,
LV), its microscopically determined border area (also LV) and the non-
infarcted area (right ventricle, RV) of the heart of the same patient.
Based on pre-deﬁned criteria themyocardial infarct agewasmicroscop-
ically categorized into three phases: 1) early MI phase (death 3–12 h
after MI), 2) neutrophilic granulocyte MI phase (12 h–5 days after MI)
and 3) chronic MI phase (5–14 days after MI) [5]. Of each of the
infarct-related coronary arteries, the grade of stenosis was calculated
(lumen surface/lumen+ intima surface, in percentage) and categorized
into 4 groups: 0–25%, 25–50%, 50–75% and 75–100%.
Tissue-slides were stained with CD45 (lymphocytes), CD68 (macro-
phages), tryptase (mast cells), myeloperoxidase (neutrophilic
granulocytes) and the advanced glycation end product N-epsilon-
(carboxymethyl)lysine (CML) and subsequently quantiﬁed by two
Fig. 1. Immunohistochemical analysis of N-epsilon-(carboxymethyl)lysine (CML) and Inﬂamma
A. N-epsilon-(carboxymethyl)lysine in heart tissue. B. Inﬂammatory cell densities in left ventric
cell densities in right ventricle non-infarcted area. MPO=neutrophilic granulocytes, CD45= ly
interquartile range (IQR), p b 0.05 was considered signiﬁcant.
Table 1
Study population characteristics.
Characteristics Rheumatoid
arthritis
(n = 5)
controls
(n
= 5)
Demographics
Age, years 78 ± 6 76 ± 8
Male gender 2 (40) 2 (40)
Stay at ICU/CCU before death 1 (20) 1 (20)
Cardiovascular risk factors
Hypertension 2 (40) 2 (40)
Dyslipidemia 1 (20) 1 (20)
Diabetes mellitus 0 0
Prior myocardial infarction 3 (60) 2 (40)
Prior other vascular disease 1 (20) 1 (20)
Inﬂammatory disease characteristics
Duration of rheumatoid arthritis (years) 6.6 (1.3–24.5) –
Number of infarct related epicardial coronary
artery slides, n
12 11
Left artery descending 6 5
Right coronary artery 0 2
Ramus circumﬂexus 6 4
Grade of stenosis, 0–100%, median (IQR) 30 (21–44) 21
(20–33)
Coronary stenosis grade in percentage, n
0–25 5 7
25–50 5 3
50–75 1 1
75–100 1 0
Total amount of myocardial slides, n 65 66
Amount of slides infarct area (LV) 21 23
Amount of slides border area (LV) 25 22
Amount of slides of non-infarct area (RV) 19 21
Infarction phase per patient, n
Phase 1 (3–12 h) 0 0
Phase 2 (12 h-5 days) 2 2
Phase 3 (5–14 days) 3 3
Infarct location per patient, n
Anterior 2 2
Posterior 3 3
Inferior 0 1
Lateral 1 1
Septal 2 1
Results presented as means± standard deviations, number (percentages) or median (in-
terquartile range) n number, IQR interquartile range, LV left ventricle, RV right ventricle.
75Correspondenceinvestigators (AMS and IAMO) [7]. In the myocardial slides, the
intramyocardial coronary arteries positive for CMLwere given an inten-
sity score: 1 = weak positivity; 2 = moderate positivity; 3 = strong
positivity. The CML intensity score [1–3] was multiplied by the amount
of intramyocardial coronary arteries positive for that score. The surfaces
of the myocardial tissue slides and of the coronary slides were
measured, using a video overlay system, the Q-PRODIT 5.2 (Leica,
Cambridge, UK), whereby a computer was linked to a camera placed
on a microscope. Finally, cell density (cells/mm2) and CML positivity
(immunohistochemical score/mm2) were calculated by dividing the
number of cells or the CML intensity score respectively, by the surface
of the tissue component of interest. Mann–Whitney tests were used
for statistical analyses. Subject characteristics are presented as number
and percentage, mean ± standard deviation or median + interquartile
range (IQR) in case of a skewed distribution. Two sided p-values less
than 0.05 were considered statistically signiﬁcant. All analyses were
performed by SPSS 19.0 (Chicago, IL, USA).
In total, ﬁve subjects with RA and MI and ﬁve controls with MI but
without RA were included in this study. The patient and tissue slide
characteristics are presented in Table 1. The characteristics were not
signiﬁcantly different between RA patients and controls.
In the adventitial layer of the infarct related epicardial coronary
artery of RA patients signiﬁcantly more lymphocytes (9.1 (3.8–29.7) vs
3.6 (1.8–5.5), p = 0.01) and mast cells (5.0 (1.7–7.4) vs. 1.3 (1.0–2.7),
p = 0.02) were found compared to controls. Except for a signiﬁcantly
lower cell density for neutrophilic granulocytes (1.7 (0.0–4.0) vs 5.7
(5.1–15.7), p=0.02) in the intima of RApatients, no other signiﬁcant dif-
ferences in inﬂammatory cell count in the intima, media and adventitia
were found in RA patients compared to controls.
The results of the analyses of the CML intensity score and inﬂamma-
tory cells within the heart tissue slides are depicted in Fig. 1. In the
infarct area, CML intensity score (1.3 IQR 0.8–1.8 vs. 0.1 IQR 0.1–0.3 im-
munohistochemical score/mm2) andmast cell count (3.4 IQR2.4–4.1 vs.
2.1 IQR 1.4–2.7 cells/mm2) were signiﬁcantly higher in RA patients
compared to controls. In the border area, CML intensity scores and the
numbers of lymphocytes and macrophages were signiﬁcantly higher
in theRAversus control group (0.7 IQR0.4–1.3 vs. 0.3 IQR0.2–0.5 immu-
nohistochemical score/mm2, 15.6 IQR 9.9–20.8 vs. 8.7 IQR
4.9–13.2 cells/mm2and 14.6 IQR 6.7–23.9 vs. 8.5 IQR 4.4–13.5 cells/
mm2, respectively).tory cell densities in the heart tissue of rheumatoid arthritis (RA) patients versus controls.
le infarct area. C. Inﬂammatory cell densities in left ventricle border area. D. Inﬂammatory
mphocytes, CD68=macrophages, tryptase=mast cells. Results are shown asmedian and
76 CorrespondenceAlso in thenon-infarcted RVCML intensity scores (0.7 IQR0.5–1.6 vs.
0.4 IQR 0.2–0.7 immunohistochemical score/mm2, p = 0.005) and the
number of mast cells (2.9 IQR 2.1–3.8 vs. 1.9 IQR 1.3–2.7 cells/mm2)
were signiﬁcantly higher in RA patients compared to controls.
In conclusion, this study shows that the inﬂammatory status is
increased in RA patients withMI at different levels, namely 1) in the ad-
ventitia of infarct related epicardial coronary arteries; 2) in the
intramyocardial vasculature and 3) in the border area of the infarcted
heart, compared with controls. These ﬁndings support the hypothesis
that RA patients are prone to develop more vulnerable plaques due to
more inﬂammation in the coronary arteries, but also develop increased
intramyocardial inﬂammation indicative for a higher risk onmyocardial
tissue damage postMI. Thismight not only explain the higher incidence
of cardiovascular events in this population, but also the higher fatality
rate after myocardial infarction.
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